Birdwatch Archive

Birdwatch Note Rating

2023-05-20 22:37:42 UTC - HELPFUL

Rated by Participant: A1BD86478ED6EAA00AFA024D962405AE5EBCF22CD86959C8B4BC13384A5F6B41
Participant Details

Original Note:

A phase three trial found Pfizer’s shot was nearly 82% effective at preventing severe disease from RSV in newborns during the first 90 days of life. RSV is a leading cause of hospitalization in children <1 year of age. https://pubmed.ncbi.nlm.nih.gov/23878043/ https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-positive-top-line-data-phase-3-global

All Note Details

Original Tweet

All Information

  • noteId - 1660048150072098818
  • participantId -
  • raterParticipantId - A1BD86478ED6EAA00AFA024D962405AE5EBCF22CD86959C8B4BC13384A5F6B41
  • createdAtMillis - 1684622262025
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 1
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1660048150072098818A1BD86478ED6EAA00AFA024D962405AE5EBCF22CD86959C8B4BC13384A5F6B41